POLCHI, ALICE
 Distribuzione geografica
Continente #
NA - Nord America 720
EU - Europa 606
AS - Asia 155
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 1.486
Nazione #
US - Stati Uniti d'America 720
IT - Italia 189
IE - Irlanda 139
UA - Ucraina 78
CN - Cina 48
HK - Hong Kong 35
FI - Finlandia 31
RU - Federazione Russa 29
FR - Francia 28
SE - Svezia 26
GB - Regno Unito 25
TR - Turchia 25
DE - Germania 22
BE - Belgio 12
IR - Iran 12
NL - Olanda 12
SG - Singapore 12
IN - India 8
UZ - Uzbekistan 7
CH - Svizzera 5
VN - Vietnam 5
AT - Austria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
EG - Egitto 1
EU - Europa 1
LB - Libano 1
MA - Marocco 1
PL - Polonia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 1.486
Città #
Chandler 161
Dublin 139
Perugia 94
San Mateo 76
Ann Arbor 61
Jacksonville 46
Hong Kong 34
Medford 34
Princeton 34
Wilmington 27
Izmir 25
Andover 24
Altamura 23
Beijing 20
Lawrence 17
Ashburn 16
Brussels 11
Des Moines 9
Isfahan 9
Singapore 9
Boardman 8
Dronten 8
Falls Church 8
Rome 8
Saint Petersburg 8
Edinburgh 7
Woodbridge 6
Dong Ket 5
Florence 5
Houston 5
Redwood City 5
Los Angeles 4
New York 4
Norwalk 4
San Paolo di Civitate 4
Cattolica 3
Chicago 3
Den Haag 3
Detroit 3
Redmond 3
Rende 3
Rājsamand 3
Shanghai 3
Taranto 3
Aci Sant'Antonio 2
Helsinki 2
Jesi 2
Lequile 2
Macerata 2
Milan 2
Nanjing 2
Padova 2
Pune 2
Reggio Emilia 2
San Diego 2
Santiago De Compostela 2
Shenyang 2
Tehran 2
Valenzano 2
Albano Laziale 1
Birmingham 1
Bologna 1
Chengdu 1
Clearwater 1
Esslingen am Neckar 1
Fairfield 1
Groningen 1
Hangzhou 1
Hebei 1
Kaohsiung 1
Kiev 1
Lausanne 1
Mansourah 1
Moscow 1
Mulhouse 1
Mühldorf 1
Rabat 1
Sessa Aurunca 1
Tabriz 1
Tappahannock 1
Watermael-Boitsfort 1
Totale 1.037
Nome #
FORMULAZIONE E CARATTERIZZAZIONE DI NUOVI TIPI DI NANOPARTICELLE PER STRATEGIE DI “DRUG DELIVERY” A LIVELLO CEREBRALE 87
RAPAMYCIN LOADED SOLID LIPID NANOPARTICLES: FORMULATION, CHARACTERIZATION AND INHIBITION OF mTORC1 ACTIVITY IN SH-SY5Y NEUROBLASTOMA CELLS. 68
Methods to Discriminate the Distribution of Acidic Glycohydrolases Between the Endosomal–Lysosomal Systems and the Plasma MembraneEndosome Signaling Part A 67
Oncogenic H-Ras Up-Regulates Acid β-Hexosaminidase by a Mechanism Dependent on the Autophagy Regulator TFEB 65
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard 63
Jurkat T-cell stimulation up-regulates the expression of lysosomal β-hexosaminidase and β-galactosidase and triggers their recruitment to lipid microdomains 59
Glycohydrolases β-hexosaminidase and β-galactosidase are associated with lipid microdomains of Jurkat T-lymphocytes 59
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 59
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 59
NANOPARTICLE-DRIVEN DRUG DELIVERY TO THE CNS: COMPARISON OF PLGA AND LIPID-BASED NAOPARTICLES IN MOUSE MODEL OF NEURODEGENERATIVE DISEASES 58
Extending lifespan through autophagy stimulation: a future perspective 55
β-Hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells 54
Plasma membrane β-galactosidase and β-hexosaminidase are associated to lipid raft of Jurkat T-cell upon raft clustering. 53
TFEB activation promotes the recruitment of lysosomal glycohydrolases β-hexosaminidase and β-galactosidase to the plasma membrane 52
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 51
PROTEIN EXPRESSION PROFILE OF PLASMEPSIN IV KNOCK DOWN PLASMODIUM BERGHEI PARASITE AND IMMUNOREACTIVE IDENTIFICATION 50
Human lysosomal α-D-mannosidase regulation in promyelocytic leukaemia cells. 49
Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization 47
Curcumin Analogue C1 Promotes Hex and Gal Recruitment to the Plasma Membrane via mTORC1-Independent TFEB Activation 45
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 41
β-Hexosaminidase α-subunit overexpression affects lipid microdomain glycohydrolases content 40
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 40
Drug delivery strategies for mTOR inhibitors therapy in neurodegenerative and neuro-oncologic disease. 40
Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies 39
Modified PLGA-NPS able to cross the blood-brain barrier for the delivery of lysosomal enzymes in llysosomal storage disease 37
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model 36
Recruitment of plasma membrane β-galactosidase and β-hexosaminidase in lipid rafts upon T-cell activation 35
Rapamycin-loaded solid lipid nanoparticles for brain targeting 33
Regulation of lysosomal genes by miRNA 32
Rapamycin-loaded solid lipid nanoparticles: morphology and impact of the drug loading on the phase transition between lipid polymorphs 32
Solid lipid nanoparticle as a tool to deliver mTOR inhibitors 30
Everolimus treatment reduces proliferation of TSC1-deficient adult neural stem/progenitor cells and restores their migration capability. 28
RECENT DEVELOPMENTS IN THERAPEUTIC APPROACHES FOR LYSOSOMAL STORAGE DISORDERS 27
Signaling Pathways in Exosomes Biogenesis, Secretion and Fate 27
Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells 8
Totale 1.625
Categoria #
all - tutte 6.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 30 2
2019/2020135 11 5 13 8 19 1 17 13 14 19 13 2
2020/2021209 2 16 3 13 83 9 13 5 35 4 18 8
2021/2022286 3 48 4 5 10 4 7 103 12 16 32 42
2022/2023487 34 85 7 40 56 47 0 20 175 3 17 3
2023/2024178 27 15 18 5 7 12 42 1 8 8 35 0
Totale 1.625